文献速递临床试验与 GCP组学、生物样本库与精准医学

剖宫产术中母亲抗生素给药时机对婴儿肠道微生物定植的影响(MAMI试验):随机对照试验研究方案

The influence of timing of Maternal administration of Antibiotics during cesarean section on the intestinal Microbial colonization in Infants (MAMI-trial): study protocol for a randomised controlled trial.
PubMed 文献 · Trials · 2019-08-05

本研究为单中心随机对照试验,计划招募40名择期剖宫产产妇,随机分为皮肤切开前静脉给予头孢呋辛1500 mg组(n=20)或脐带钳夹后给药组(n=20),并设阴道分娩婴儿(n=20)作为肠道菌群对照。通过16S测序分析婴儿出生后第1、7、28天及2岁时粪便样本,评估给药时机对新生儿肠道定植的影响。

要点

  • 择期剖宫产产妇随机分为皮肤切开前或脐带钳夹后静脉给予头孢呋辛1500 mg。
  • 将剖宫产婴儿肠道菌群与阴道分娩婴儿(n=20)进行比较。
  • 粪便样本于出生后第1、7、28天及2岁时采集,行16S测序分析。

核心结论

  • 本研究旨在探讨剖宫产术中母亲抗生素给药时机对新生儿至2岁肠道定植过程的影响。

研究设计与样本

  • 单中心随机对照试验,计划招募40名择期剖宫产产妇,随机分为皮肤切开前给药组(n=20)和脐带钳夹后给药组(n=20),两组均静脉给予头孢呋辛1500 mg。
  • 另设阴道分娩婴儿(n=20)作为肠道菌群对照。
  • 对暴露新生儿检测脐血中头孢呋辛水平。
  • 于出生后第1、7、28天及2岁时采集儿童粪便样本,行16S测序分析。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A disturbance in the early colonisation of the gut by microorganisms is associated with an aberrant innate immune system and a variety of clinical conditions later in life. Several factors are considered to influence this initial colonisation, including maternally administered antibiotics during pregnancy and delivery. Recent revisions to international obstetric guidelines have resulted in the exposure of all infants born by caesarean section (CS) to broad-spectrum antibiotics perinatally. To date, the consequences of these new guidelines on neonatal gut colonisation and the associated short- and long-term health implications have not yet been addressed. The aim of this study is to investigate the influence of the timing of antibiotic administration during CS to the mother on the course of neonatal intestinal colonisation up to 2 years of age. METHODS/DESIGN: This single-centre randomised controlled trial will recruit 40 women scheduled for an elective CS. The subjects will be randomised to receive 1500 mg of cefuroxime intravenously either prior to the skin incision (n = 20) or after clamping of the umbilical cord (n = 20). Levels of cefuroxime in cord blood will be determined for exposed neonates. Faecal samples from the children will be collected on days 1, 7 and 28 days and at 2 years old and analysed by 16S sequencing. Shannon-diversity indices, absolute and relative abundances, and unsupervised and supervised classification methods will be used to evaluate the effect of the timing of intrapartum cefuroxime administration on the composition of the microbiota. The outcomes for both study groups will be compared to the intestinal microbiota of vaginally born infants (n = 20). To detect possible effects on health state, a questionnaire on health-related issues will be taken at the age of 2 years. DISCUSSION: In the proposed study, changes in the intestinal microbiota of 40 children born by CS will be followed until the age of 2 years. Research on this topic is necessary since significant effects relating to the timing of antibiotic administration on microbial colonisation may conflict with the current guidelines, as this may have health consequences later in life. TRIAL REGISTRATION: Netherlands Clinical Trial Registry, NTR6000 . Retrospectively registered on 25 July 2016.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Dierikx TH, Berkhout DJC, Visser L, et al. The influence of timing of Maternal administration of Antibiotics during cesarean section on the intestinal Microbial colonization in Infants (MAMI-trial): study protocol for a randomised controlled trial. Trials. 2019. PMID: 31382981. doi:10.1186/s13063-019-3552-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。